Why is Nureca Ltd ?
1
Weak Long Term Fundamental Strength with a -143.07% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 5.62% signifying low profitability per unit of shareholders funds
2
With a growth in Net Profit of 348.15%, the company declared Very Positive results in Sep 25
- The company has declared positive results for the last 3 consecutive quarters
- PAT(Q) At Rs 3.63 cr has Grown at 5449355549118300160.0% (vs previous 4Q average)
- NET SALES(Q) Highest at Rs 37.74 cr
- PBDIT(Q) Highest at Rs 3.28 cr.
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 5.91%, its profits have risen by 246.8% ; the PEG ratio of the company is 0.3
4
Rising Promoter Confidence
- Promoters have increased their stake in the company by 0.64% over the previous quarter and currently hold 64.97% of the company
- Promoters increasing their stake is a sign of high confidence in the future of the business
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Nureca for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Nureca
-14.89%
0.10
58.93%
Sensex
-5.12%
0.44
11.83%
Quality key factors
Factor
Value
Sales Growth (5y)
-7.19%
EBIT Growth (5y)
-149.52%
EBIT to Interest (avg)
2.91
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.72
Tax Ratio
58.23%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.51%
ROCE (avg)
5.36%
ROE (avg)
4.74%
Valuation Key Factors 
Factor
Value
P/E Ratio
110
Industry P/E
93
Price to Book Value
1.26
EV to EBIT
-103.07
EV to EBITDA
187.60
EV to Capital Employed
1.33
EV to Sales
1.28
PEG Ratio
0.70
Dividend Yield
NA
ROCE (Latest)
-1.29%
ROE (Latest)
1.15%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
9What is working for the Company
NET SALES(Latest six months)
At Rs 75.05 cr has Grown at 28.95%
PAT(9M)
Higher at Rs 1.27 Cr
-7What is not working for the Company
PAT(Q)
At Rs -6.09 cr has Fallen at -328.9% (vs previous 4Q average
PBDIT(Q)
Lowest at Rs -5.77 cr.
OPERATING PROFIT TO NET SALES (Q)
Lowest at -16.29%
PBT LESS OI(Q)
Lowest at Rs -6.53 cr.
EPS(Q)
Lowest at Rs -6.38
Loading Valuation Snapshot...
Here's what is working for Nureca
Net Sales - Latest six months
At Rs 75.05 cr has Grown at 28.95%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Nureca
Profit After Tax (PAT) - Quarterly
At Rs -6.09 cr has Fallen at -328.9% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 2.66 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs -5.77 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Lowest at -16.29%
in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -6.53 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs -6.38
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)